Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenji Hibi

Showing results (1-10 of 112) with videos related to

Pageof 12
Sort By:
Anticancer Research|February 16, 2006
Lymph node metastasis is infrequent in patients with highly-methylated colorectal cancerKenji Hibi, Akimasa Nakao
Anticancer Research|January 5, 2007
Highly-methylated colorectal cancers show poorly-differentiated phenotypeKenji Hibi, Akimasa Nakao
Anticancer Research|July 31, 2014
Serum vimentin methylation as a potential marker for colorectal cancerAtsushi Shirahata, Kenji Hibi
Anticancer Research|November 11, 2006
Aberrant methylation is frequently observed in advanced esophageal squamous cell carcinomaTomoki Fukuoka, Kenji Hibi, Akimasa Nakao
Hepato-Gastroenterology|June 6, 2014
p16 Methylation is frequently detected in the serum of metastatic colorectal cancer patientsKenji Hibi, Hiroki Mizukami, Mitsuo Saito, et al.
Diseases of the Colon and Rectum|March 29, 2005
Aberrant methylation of HLTF, SOCS-1, and CDH13 genes is shown in colorectal cancers without lymph node metastasisKenji Hibi, Yasuhiro Kodera, Katsuki Ito, et al.
Nagoya Journal of Medical Science|July 29, 2004
Prolonged cytostatic tumor dormancy induced by serial exchange of chemotherapy in colorectal carcinomaKatsuki Ito, Kenji Hibi, Yasuhiro Kodera, et al.
Nagoya Journal of Medical Science|September 24, 2008
Mucinous cystadenoma of the appendix associated with muscular and neuromatous hyperplasia: report of a caseKenji Hibi, Misako Mizutani, Masahiko Imazawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2004
Plasminogen activator inhibitor-1 as a potential marker for the malignancy of esophageal squamous cell carcinomaTakumi Sakakibara, Kenji Hibi, Yasuhiro Kodera, et al.
Anticancer Research|March 2, 2005
Plasminogen activator inhibitor-1 is a downstream mediator of the PGP9.5-related oncogenic pathway in esophageal squamous cell carcinomaKenji Hibi, Yasuhiro Kodera, Katsuki Ito, et al.
Pageof 12

Showing results (1-10 of 112) with videos related to

Sort By:
Pageof 12
Anticancer Research|February 16, 2006
Lymph node metastasis is infrequent in patients with highly-methylated colorectal cancerKenji Hibi, Akimasa Nakao
Anticancer Research|January 5, 2007
Highly-methylated colorectal cancers show poorly-differentiated phenotypeKenji Hibi, Akimasa Nakao
Anticancer Research|July 31, 2014
Serum vimentin methylation as a potential marker for colorectal cancerAtsushi Shirahata, Kenji Hibi
Anticancer Research|November 11, 2006
Aberrant methylation is frequently observed in advanced esophageal squamous cell carcinomaTomoki Fukuoka, Kenji Hibi, Akimasa Nakao
Hepato-Gastroenterology|June 6, 2014
p16 Methylation is frequently detected in the serum of metastatic colorectal cancer patientsKenji Hibi, Hiroki Mizukami, Mitsuo Saito, et al.
Diseases of the Colon and Rectum|March 29, 2005
Aberrant methylation of HLTF, SOCS-1, and CDH13 genes is shown in colorectal cancers without lymph node metastasisKenji Hibi, Yasuhiro Kodera, Katsuki Ito, et al.
Nagoya Journal of Medical Science|July 29, 2004
Prolonged cytostatic tumor dormancy induced by serial exchange of chemotherapy in colorectal carcinomaKatsuki Ito, Kenji Hibi, Yasuhiro Kodera, et al.
Nagoya Journal of Medical Science|September 24, 2008
Mucinous cystadenoma of the appendix associated with muscular and neuromatous hyperplasia: report of a caseKenji Hibi, Misako Mizutani, Masahiko Imazawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2004
Plasminogen activator inhibitor-1 as a potential marker for the malignancy of esophageal squamous cell carcinomaTakumi Sakakibara, Kenji Hibi, Yasuhiro Kodera, et al.
Anticancer Research|March 2, 2005
Plasminogen activator inhibitor-1 is a downstream mediator of the PGP9.5-related oncogenic pathway in esophageal squamous cell carcinomaKenji Hibi, Yasuhiro Kodera, Katsuki Ito, et al.
Pageof 12